Emily K. Schutsky

574 total citations
8 papers, 396 citations indexed

About

Emily K. Schutsky is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Emily K. Schutsky has authored 8 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Epidemiology and 1 paper in Infectious Diseases. Recurrent topics in Emily K. Schutsky's work include Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (4 papers) and Cancer-related gene regulation (2 papers). Emily K. Schutsky is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (4 papers) and Cancer-related gene regulation (2 papers). Emily K. Schutsky collaborates with scholars based in United States. Emily K. Schutsky's co-authors include Rahul M. Kohli, Jamie E. DeNizio, Christopher S. Nabel, Monica Yun Liu, Scott C. Garman, Adriana Kita, Hao Wu, Emily Fabyanic, Frederic D. Bushman and Peng Hu and has published in prestigious journals such as Nucleic Acids Research, Nature Biotechnology and Journal of Molecular Biology.

In The Last Decade

Emily K. Schutsky

8 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily K. Schutsky United States 8 324 60 45 41 39 8 396
Suk-Youl Park South Korea 5 271 0.8× 22 0.4× 24 0.5× 26 0.6× 17 0.4× 7 352
Yukiko Fukuhara Japan 7 129 0.4× 117 1.9× 69 1.5× 48 1.2× 14 0.4× 11 364
Zhihe Kuang Australia 10 298 0.9× 41 0.7× 20 0.4× 49 1.2× 26 0.7× 18 393
T. Antoshenko Canada 4 316 1.0× 47 0.8× 104 2.3× 11 0.3× 23 0.6× 4 466
Guy S. Salvesen United States 6 215 0.7× 19 0.3× 86 1.9× 36 0.9× 13 0.3× 7 293
Robert H. Brady United States 6 144 0.4× 20 0.3× 137 3.0× 19 0.5× 32 0.8× 7 310
Lydia Lamriben United States 4 215 0.7× 26 0.4× 31 0.7× 11 0.3× 34 0.9× 4 322
Sylvain Lanouette Canada 7 460 1.4× 17 0.3× 9 0.2× 24 0.6× 9 0.2× 9 501
Elisabeth Mohorko Switzerland 6 322 1.0× 22 0.4× 28 0.6× 15 0.4× 63 1.6× 6 389
Vanessa Masson France 7 201 0.6× 19 0.3× 10 0.2× 21 0.5× 15 0.4× 9 337

Countries citing papers authored by Emily K. Schutsky

Since Specialization
Citations

This map shows the geographic impact of Emily K. Schutsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily K. Schutsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily K. Schutsky more than expected).

Fields of papers citing papers by Emily K. Schutsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily K. Schutsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily K. Schutsky. The network helps show where Emily K. Schutsky may publish in the future.

Co-authorship network of co-authors of Emily K. Schutsky

This figure shows the co-authorship network connecting the top 25 collaborators of Emily K. Schutsky. A scholar is included among the top collaborators of Emily K. Schutsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily K. Schutsky. Emily K. Schutsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wang, Tong, Laura Liu, Emily K. Schutsky, et al.. (2023). Direct enzymatic sequencing of 5-methylcytosine at single-base resolution. Nature Chemical Biology. 19(8). 1004–1012. 33 indexed citations
2.
Berríos, Kiara N., et al.. (2022). The Base-Editing Enzyme APOBEC3A Catalyzes Cytosine Deamination in RNA with Low Proficiency and High Selectivity. ACS Chemical Biology. 17(3). 629–636. 12 indexed citations
3.
Wang, Tong, et al.. (2020). Bisulfite-Free Sequencing of 5-Hydroxymethylcytosine with APOBEC-Coupled Epigenetic Sequencing (ACE-Seq). Methods in molecular biology. 2198. 349–367. 10 indexed citations
4.
DeNizio, Jamie E., Emily K. Schutsky, Kiara N. Berríos, Monica Yun Liu, & Rahul M. Kohli. (2018). Harnessing natural DNA modifying activities for editing of the genome and epigenome. Current Opinion in Chemical Biology. 45. 10–17. 12 indexed citations
5.
Schutsky, Emily K., Jamie E. DeNizio, Peng Hu, et al.. (2018). Nondestructive, base-resolution sequencing of 5-hydroxymethylcytosine using a DNA deaminase. Nature Biotechnology. 36(11). 1083–1090. 152 indexed citations
6.
Schutsky, Emily K., et al.. (2017). APOBEC3A efficiently deaminates methylated, but not TET-oxidized, cytosine bases in DNA. Nucleic Acids Research. 45(13). 7655–7665. 69 indexed citations
7.
Liu, Monica Yun, Jamie E. DeNizio, Emily K. Schutsky, & Rahul M. Kohli. (2016). The expanding scope and impact of epigenetic cytosine modifications. Current Opinion in Chemical Biology. 33. 67–73. 22 indexed citations
8.
Schutsky, Emily K., et al.. (2012). The Structure of Human GALNS Reveals the Molecular Basis for Mucopolysaccharidosis IV A. Journal of Molecular Biology. 423(5). 736–751. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026